See the Complete Picture.

Browser Extension

Monday, May 19, 2025

US Edition

Subscribe Login

Israel-Hamas Conflict

Natural Disasters

Champions League

Artificial Intelligence

Drug Discovery and Development image

News from Drug Discovery and Development

Topics Most Covered by Drug Discovery and Development

Artificial Intelligence

Artificial Intelligence

Sources Covering Similar Topics

Hastings Tribune

Plato. Vertical Search. Ai. | PlatoAiStream. Data Intelligence. Vertical Search. Ai.

Anti-Aging, Acupuncture and Health News

Managed Healthcare Executive

Hastings Tribune

Plato. Vertical Search. Ai. | PlatoAiStream. Data Intelligence. Vertical Search. Ai.

Suggest a source

Looking for a source we don't already have? Suggest one here.

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Social Media Natural Disasters NBA Formula 1 Cricket

Trending in U.S.Israel-Hamas Conflict Baseball NBA US Politics Donald Trump

Trending in U.K.Israel-Hamas Conflict Premier League Celtic Arsenal FC Soccer

Trending Topics

Social Media Natural Disasters NBA Formula 1 Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from Drug Discovery and Development

Stay current with all the latest and breaking news from Drug Discovery and Development. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve discovered 41 headlines written by Drug Discovery and Development during the past 3 months.

Drug Discovery and Development’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Drug Discovery and Development’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Stay current with all the latest and breaking news from Drug Discovery and Development. Compare headlines and media bias behind news outlets on stories breaking today. We’ve discovered 41 headlines written by Drug Discovery and Development during the past 3 months.

Drug Discovery and Development’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Drug Discovery and Development’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Drug Discovery and Development

Where is Drug Discovery and Development located?Drug Discovery and Development's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Drug Discovery and Development News

FDA says it will be 'aggressive' in adopting artificial intelligence in its labs

Artificial Intelligence · United States

FDA says it will be 'aggressive' in adopting artificial intelligence in its labs

50% Center coverage: 12 sources

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline that includes an AI-assisted scientific review pilot.See the Story

**XingImaging Unveils NX PET Camera to Advance Parkinson's Disease Research**

Parkinson's Disease

XingImaging Unveils NX PET Camera to Advance Parkinson's Disease Research

100% Center coverage: 2 sources

NEW HAVEN, Conn., May 6, 2025 /PRNewswire/ -- XingImaging, a MITRO company, a pioneer in advanced research imaging, radiopharmaceutical services, and medical imaging technology, proudly announces the launch of the **NX PET Camera**, a breakthrough in positron emission tomography (PET)…See the Story

Intrepid Labs Launches to Transform Drug Formulation with AI and Autonomous Labs

Artificial Intelligence · Toronto

Intrepid Labs Launches to Transform Drug Formulation with AI and Autonomous Labs

100% Center coverage: 1 sources

TORONTO--(BUSINESS WIRE)--May 12, 2025-See the Story

Altice USA Partners with Google Cloud to Boost Its AI Agents’ Capabilities

Altice USA Partners with Google Cloud to Boost Its AI Agents’ Capabilities

Altice USA is collaborating with Google Cloud to enhance the capabilities of its artificial intelligence agents. The partnership aims to leverage advanced cloud technologies to improve customer service operations and optimize digital interactions for Altice’s clients across the United States.Artificial Intelligence See the Story

Newly discovered ‘super stem cells’ can transform into better versions of themselves

Newly discovered ‘super stem cells’ can transform into better versions of themselves

100% Left coverage: 1 sources

Researchers just discovered super stem cells capable of resetting themselves back to a stronger, younger version.Atlanta, Georgia · Atlanta See the Story

Elsevier adds 500,000 ClinicalTrials.gov records into Embase

Elsevier adds 500,000 ClinicalTrials.gov records into Embase

Elsevier has pushed roughly half a million ClinicalTrials.gov entries into Embase, its subscription biomedical database. The May 6 update lets R&D teams run a single search that pulls trial data from 200‑plus countries and matches it with Embase’s peer‑reviewed papers, in‑press manuscripts and conference abstracts. Elsevier notes that traditional approaches to synthesizing data from multiple sources… The post Elsevier plugs 500,000 ClinicalTria…London, England · London See the Story

From 1.5% to 5.9%: Deloitte explores what's fueling Big Pharma's R&D IRR climb

From 1.5% to 5.9%: Deloitte explores what's fueling Big Pharma's R&D IRR climb

Pharma’s long winter of diminishing R&D returns may be thawing. Despite decades of increased spending yielding less bang for the buck, the industry is regaining ground. Deloitte’s closely watched annual analysis charted the slide, with average forecast IRR falling from just over 10% in Deloitte’s inaugural 2010 analysis to a trough of just 1.5% by 2019, a… The post From 1.5% to 5.9%: Deloitte digs into what’s fueling Big Pharma’s R&D IRR climb a…Pharma Read Article

MIT team designs gene circuits for precise control in gene therapy study

MIT team designs gene circuits for precise control in gene therapy study

An MIT research group has unveiled a set of synthetic gene circuits designed to give scientists more control over gene-therapy treatments, according to a recent paper. The study, appearing in the journal Cell Systems, describes genetic constructs meant to fine-tune how and when therapeutic genes are switched on inside a patient’s cells, aiming to keep… The post MIT team designs gene circuits for tighter control in gene therapy study appeared fi…Cambridge, Massachusetts · Cambridge Read Article

Asembia AXS25: Cell and Gene Therapies Enter New Phase of Growth in Specialty Pharmacy

Asembia AXS25: Cell and Gene Therapies Enter New Phase of Growth in Specialty Pharmacy

As the cell and gene therapy pipeline expands, experts at Asembia’s AXS25 Summit emphasized the need for error-proof logistics, value-based access strategies, and coordinated reimbursement models.United States · United States See the Story

The importance of a sound AI policy in pharma research and development

The importance of a sound AI policy in pharma research and development

From accelerating drug discovery and optimizing clinical trials to automating regulatory documentation and improving patient engagement, AI offers opportunities to improve efficiency, reduce costs, and bring therapies to market faster. However, as AI tools become more integrated into research and development (R&D) workflows, they also introduce new risks, especially related to data privacy, intellectual property… The post Safeguarding innovation…Artificial Intelligence Read Article

Lokavant’s Spectrum turns clinical-trial planning into a live simulation

Lokavant’s Spectrum turns clinical-trial planning into a live simulation

The clinical-trial intelligence company Lokavant has debuted Spectrum, an AI-powered tool that crunches weeks of feasibility work down to minutes. Pfizer, an early adopter, now refreshes enrollment and timeline projections almost in real time. “Instead of it being five weeks to five minutes, essentially it’s a simulation every five minutes,” said Jonathan Crowther, Pfizer’s head… The post Lokavant’s Spectrum turns clinical-trial planning into a …United States · United States Read Article

Breaking News Topics Related to Drug Discovery and Development

Massachusetts

Medical

United States

Artificial Intelligence

Canada

Health

Similar News Topics

Managed Healthcare Executive

Verywell Health

Heti Világgazdaság

pokonews.com

Science Alert